Market Scenario The Erythropoietin Drugs Market is expected to reach USD 19,800.56 Million by 2030 at 11.2% CAGR during the forecast period 2022-2030. Erythropoietin is also known as hematopoietin. Erythropoietin is a hormone responsible for formation of red blood cells, it is secreted by kidneys and it promotes formation of red blood cells from bone marrow. This process is known as...